Arie Zask

Title: Arie Zask: Innovator in Pharmaceutical Chemistry

Introduction

Arie Zask is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on pyridopyrimidine compounds. His research focuses on developing compounds that can serve as mTOR inhibitors, which are crucial in treating diseases related to the malfunction of the PI3K-AKT-mTOR signaling pathway.

Latest Patents

Arie Zask holds a patent for a pyridopyrimidine or pyrimidopyrimidine compound, along with its preparation method, pharmaceutical composition, and various uses. This invention is represented by a general formula and includes isomers, pharmaceutically acceptable salts, esters, prodrugs, or solvates. The compound is particularly valuable in the development of mTOR inhibitors, which can be used to address various medical conditions.

Career Highlights

Throughout his career, Arie Zask has worked with prominent organizations, including Shandong Luoxin Pharmaceutical Group and the Chinese Academy of Sciences. His experience in these institutions has allowed him to advance his research and contribute to the pharmaceutical industry significantly.

Collaborations

Arie Zask has collaborated with several professionals in his field, including Jingkang Shen and Ke Yu. These partnerships have enhanced his research efforts and broadened the impact of his work in pharmaceutical chemistry.

Conclusion

Arie Zask's contributions to pharmaceutical chemistry, particularly through his innovative patent on pyridopyrimidine compounds, highlight his role as a key inventor in the field. His work continues to influence the development of important medical treatments.